Endocrine Board Review 2019 (live course)
Endocrine Board Review 2019 (live course)
The Endocrine Society’s Endocrine Board Review (EBR) is a live, two-day case-based course designed as a mock exam with rapid-fire questions. Clinical case questions are designed for those preparing for their board exam or for those that simply want to stay date and improve their practice skills. The cases will test your knowledge on core principles and challenge in endocrinology while following the American Board of Internal Medicine blueprint for the Endocrinology, Diabetes, & Metabolism Board Certification Exam.
EBR REGISTRATION INCLUDES
- Interactive sessions with experts
- Nearly 240 case-based questions across the breadth of endocrinology
- A curriculum aligned to the ABIM blueprint
- The EBR book, online sessions, and a personalized performance report to help you continue your learning from home
THIS COURSE PAGE IS FOR THE LIVE CONFERENCE
Please follow the below links for the EBR 11th edition self-study book and EBR Online 2019.
This activity will be of substantial interest to physicians and endocrine fellows preparing for the ABIM Endocrinology, Diabetes, & Metabolism Board Certification Exam or for those that simply want to stay up to date and improve their practice skills through knowledge assessment of diagnosis, treatment, and management of endocrine conditions.
Upon completion of this educational activity, participants will be able to (or better able to):
- Enhanced medical knowledge and clinical skills across all major areas of endocrinology
- Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders
- Successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism
ENDOCRINE BOARD REVIEW PRESENTATIONS
Faculty presentations are available to view and download as PDFs for registered participants.
To view and download presentations:
- Log in to your Endocrine Society account
- Click START on the Register tab of the course
- Navigate to the COURSE MATERIALS page
ENDOCRINE BOARD REVIEW 2019 AGENDA
|Day 1: Tuesday, September 17, 2019|
|7:00 - 8:00 AM||Breakfast|
|8:00 - 8:15 AM|
Welcome & Overview of Certification Process
|8:15 - 10:00 AM|
Diabetes Board Review, Part 1
|10:00 - 10:15 AM||Break|
|10:15 -11:45 AM|
Pituitary Board Review
|11:45 AM - 1:00 PM||Lunch|
|1:00 - 2:45 PM|
Calcium & Bone Board Review
|2:45 - 3:00 PM|
Obesity & Lipids Board Review
|4:45 - 5:00 PM|
|Day 2: Wednesday, September 18, 2019|
|7:00 - 8:00 AM||Breakfast|
|8:00 - 9:45 AM|
Diabetes Board Review, Part 2
|9:45 - 10:00 AM|
Adrenal Board Review
|11:30 AM - 12:30 PM||Lunch|
|12:30 - 1:45 PM|
Female Reproduction Board Review
|1:45 - 3:00 PM|
Male Reproduction Board Review
|3:00 - 3:15 PM||Break|
|3:15 - 5:00 PM|
Thyroid Board Review
|5:00 - 5:15 PM|
Serge A. Jabbour, MD; Sidney Kimmel Medical College, Thomas Jefferson University
Richard J. Auchus, MD, PhD, University of Michigan Medical School
Carolyn B. Becker, MD, Brigham and Women’s Hospital
Andrea D. Coviello, MD, Duke University School of Medicine
Frances J. Hayes, MB BCh, BAO, Massachusetts General Hospital
Laurence Katznelson, MD, Stanford University
Michelle F. Magee, MD, Georgetown University School of Medicine
Kathryn A. Martin, MD, Massachusetts General Hospital
Elizabeth N. Pearce, MD, MSc, Boston University Medical Center
Abbie L. Young, MS, CGC, ELS(D)
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The content of this activity was developed under the supervision of the Endocrine Society’s Endocrine Board Review Committee.
The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Richard J. Auchus, MD, PhD, has served as a consultant to Adrenas Therapeutics, Corcept Therapeutics, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Quest Diagnostics, Selenity Therapeutics, and Strongbridge Biopharma; and has conducted research for Neurocrine Biosciences, Novartis Pharmaceuticals, Spruce Biosciences, and Strongbridge Biopharma.
Carolyn B. Becker, MD, receives royalties from UpToDate as a chapter author.
Andrea D. Coviello, MD, has served as a consultant and speaker to Novo Nordisk; and has received research support from Allergan, Bristol-Myers Squibb, and Regeneron.
Serge A. Jabbour, MD, has served as a consultant to AstraZeneca, Eli Lilly, and Janssen.
Laurence Katznelson, MD, has received research support from Chiasma and Novartis; and has served as an advisory board member to Chiasma and Pfizer.
Michelle F. Magee, MD, has had her institution receive research support from Lilly, Mytonomy, and Sanofi; has served as a speaker for PRIMED; and has served as a speaker and consultant to Mytonomy.
Kathryn A. Martin, MD, serves as an editor for UpToDate.
The following faculty reported no relevant financial relationships: Frances J. Hayes, MB BCh, BAO, and Elizabeth N. Pearce, MD, MSc.
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D).
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.
Use of professional judgment:
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.
Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.
POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.
PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
Click "Start" to claim CME, MOC, and Certificate of Participation
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Review your Diplomate ABIM ID Number(s)
In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:
Provide your board-certification information in your educational profile.
Your profile currently contains the following board ID numbers (must be logged in to view):
|My Name||I am Certified by the ABIM||My ABIM Number||My Date of Birth|
*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
- 14.25 ABIM MOC
- 14.25 AMA PRA Category 1 Credits™
- 14.25 CME Certificate of Participation